A Registry Study of Biomarkers in Ischemic Heart Disease ( BIOMS-IHD )
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiovascular Diseases
- Sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases
- Enrollment
- 5000
- Locations
- 1
- Primary Endpoint
- Number of hospitalizations for acute heart failure (HF)
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The registry study aims to discover biomarkers for accurate classification and risk assessment of ischemic heart disease.
Detailed Description
The purpose of this study is to discover biomarkers for early identification, diagnosis, molecular classification, and intervention based on the mechanism of ischemic heart disease（IHD）. Using mass spectrometry-based metabolomics and multimodal imaging technology, the study aims to further construct a new system for early risk stratification of IHD based on abnormal metabolites.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Current known inability to follow instructions or comply with follow-up procedures.
- •Eligible patients without informed consent form
Outcomes
Primary Outcomes
Number of hospitalizations for acute heart failure (HF)
Time Frame: These data is collected during follow-up visit at 3/6/12/24/36/48 months after discharge
Unplanned emergency visits or hospitalizations leading to HF deterioration were defined as hospitalizations for HF
Secondary Outcomes
- Number of major adverse cardiovascular events (MACE)(These data is collected during follow-up visit at 3/6/12/24/36/48 months after discharge)